Octava Pink Test To Verify Negative Mammography Results And Detect Missed Breast Cancers Receives CE Mark Designation

Accurate, Rapid, Cost-Effective Blood Test Aims to Confirm True Negative Findings While Halving the Rate of False Negative Mammography Results Eventus Diagnostics, Inc. (EventusDx) have announced that it has received CE mark designation for its Octava PinkTM breast cancer test intended for confirmatory use in women who have received negative mammography results. The National Cancer Institute (NCI) estimates that screening mammograms miss about 20% of breast cancers that are present at the time of the procedure, leading to false negative results... via Health News from Medical News Today Read More Here..